Yeramian Patrick D
SEC CIK 1358266 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | Chief Medical Off | 205.6K | — | $5.32M | 12 | 2022-01-06 | 2024-01-09 |
Most active insiders at AMLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Klee Justin B. | Co-CEO, Dir | — | $4.03M |
| 2 | Cohen Joshua B | Co-CEO, Dir | — | $4.03M |
| 3 | Mazzariello Gina | CLO | — | $1.18M |
| 4 | FRATES JAMES M | CFO | — | $708.4K |
| 5 | Bedrosian Camille L | Chief Medical Off | — | $689.0K |
| 6 | Firestone Karen | Dir | $152.2K | — |
| 7 | MILNE GEORGE M JR | Dir | — | — |
Yeramian Patrick D made no open-market trades at AMLX in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-11 | 2024-01-09 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | S - Sale | $16.33 | -2,812 | 205.6K | -1% | -$45.9K | |
| DMT | 2023-05-17 | 2023-05-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | M - OptEx | $5.68 | +12.0K | 220.4K | +6% | +$68.0K |
| DT | 2023-05-17 | 2023-05-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | S - Sale+OE | $29.03 | -12.0K | 208.4K | -5% | -$347.3K |
| DM | 2023-04-19 | 2023-04-17 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | S - Sale+OE | $30.53 | -49.6K | 208.7K | -19% | -$1.51M |
| DM | 2023-04-19 | 2023-04-17 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | M - OptEx | $0.9895 | +49.6K | 258.0K | +24% | +$49.1K |
| DA | 2023-03-24 | 2023-03-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | A - Grant | $0.00 | +9,167 | 208.4K | +5% | $0 |
| DMA | 2023-03-24 | 2023-03-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | S - Sale+OE | $31.88 | -54.6K | 201.7K | -21% | -$1.74M |
| DMA | 2023-03-24 | 2023-03-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | M - OptEx | $2.57 | +49.6K | 237.1K | +26% | +$127.3K |
| D | 2023-03-20 | 2023-03-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | A - Grant | $0.00 | +9,167 | 158.8K | +6% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | S - Sale | $31.88 | -54.6K | 149.7K | -27% | -$1.74M |
| M | 2023-01-10 | 2023-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | S - Sale | $36.30 | +2,034 | 204.9K | +1% | +$73.8K |
| D | 2022-01-10 | 2022-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Off | A - Grant | $0.00 | +28.3K | 206.3K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations